Aspirin dose and six-month outcome after an acute coronary syndrome

This publication has 27 references indexed in Scilit:

• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations
  Circulation, 2000
• Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology Recommendations of the Task Force of the European Society of Cardiology
  European Heart Journal, 2000
• Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial
  The Lancet, 1999
• A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction
  The American Journal of Cardiology, 1996
• Controlled trial of high-versus low-dose aspirin treatment after percutaneous transluminal angioplasty in patients with peripheral vascular disease
  Journal of Molecular Medicine, 1994
• The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.
  British Journal of Clinical Pharmacology, 1993
• A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg a Day) in Patients after a Transient Ischemic Attack or Minor Ischemic Stroke
  New England Journal of Medicine, 1991
• United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results
  BMJ, 1988
• Platelet Activation in Unstable Coronary Disease
  New England Journal of Medicine, 1986